RASMINE BROWN: Open Payments
NPI 1528728946 · CHEVY CHASE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$100 in 4 payments from 2 companies in 2025. Trend: 2023 $0 · 2024 $237 · 2025 $100
Food & beverage: $100
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $83 |
| Medtronic, Inc. | 1 | $17 |
Products named: Ozempic, Wegovy, INTERSTIM.
Industry payments across MD — which companies pay providers there.
